Prospective, randomized trials are clearly needed before changing clinical practice
We observed a clear correlation between GLP-1 levels in blood and in synovial fluid
Users report losing 15 to 30 pounds within their first three to four months, with some documenting losses of 50 to 64 pounds over longer periods
GLP-1 agonists, such as liraglutide and semaglutide, are increasingly used in medical weight loss due to their ability to mimic the natural hormone glucagon-like peptide-1, which is, for the most part, responsible for regulating appetite and food intake
Last reviewed: May 25, 2026 Last updated: May 25, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
How to Take GLP1 Injections in Australia: A Step by Step Patient Guide TL;DR GLP1 receptor agonist injections (including medications such as Mounjaro, Wegovy, and Ozempic) are administered once weekly as a subcutaneous injection into the stomach, thigh, or upper arm
